Greg Ryslik is a data science and machine learning executive experienced in leading AI and engineering initiatives ranging across the biotech, healthtech and fintech domains. As senior vice president at COMPASS Pathways his work focuses on developing technology to improve the therapeutic journey for patients with treatment resistant depression. Concurrently, Greg is an assistant professor of practice in the Department of Computer Science & Engineering at Ohio State University as well as an Instructor at Stanford Continuing Studies where he lectures on statistics for artificial intelligence.

Greg started his career as an actuary at PricewaterhouseCoopers in New York City. After his PhD he spent several years in Silicon Valley at companies such as Tesla Motors, Mindstrong Health and Genentech. He is a fellow of the Casualty Actuarial Society, as well as a member of the American Academy of Actuaries. In September 2020, he was named one of Boston Business Journal’s “40 under 40”.

Greg holds a PhD from Yale University in biostatistics, a master’s degree in statistics from Columbia University and an undergraduate degree in mathematics, computer science and finance from Rutgers University.

© 2022 BioFutureTM. All Rights Reserved

Produced by